Skip to main content

Table 1 Summary of the major findings on TREM2 in AD context

From: New insights into the role of TREM2 in Alzheimer’s disease

AD context

Major TREM2-AD related findings

Source

Citations

Risk factors

❖ Rare variants in TREM2 increase LOAD risk by 2- to 4- fold

AD patients

[104, 107,108,109,110,111,112,113,114,115,116,117,118]

Amyloid pathology

❖ Loss of functional TREM2 decreases microgliosis around plaques

5xFAD mice

APPPS1-21 mice

[45, 75, 130, 132, 133]

❖ Loss of functional TREM2 decreases plaque compaction

5xFAD mice

APPPS1-21 mice

[75, 89, 90, 133]

Tau pathology

❖ TREM2 deletion decreases tau-mediated neurodegeneration

PS19 mice

[152, 153]

❖ TREM2 deletion (1) or haploinsuficiency (2) increase tau pathology

hTau mice (1)

PS19 mice (2)

[151] (1)

[153] (2)

ApoE

❖ ApoE is a TREM2 ligand

in vitro

[76, 78, 79]

❖ ApoE-induced switch from homeostatic to neurodegenerative microglia is TREM2-dependent

APPPS1-21 mice

[95]